NRSNVSYDES• 3 Months (Normalized)
NRSN vs YDES (NeuroSense Therapeutics Ltd. vs YD Bio Limited)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
NRSN Performance $4.78
+%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
YDES Performance $7.53
+296.32%
YD Bio Limited
Normalized Baseline0.00%
Alpha Spread Margin YDES LEADS
-296.32 pts
YDES outperforming by 296.32 percentage points
NRSNYDES
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
NRSN YDES
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | NRSN Price | NRSN Gain (%) | YDES Price | YDES Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $- | $7.53 | +296.32% | - | |
| Sep 29, 2026 | $4.78 | +575.14% | $7.61 | +300.53% | +274.61% |
| Sep 28, 2026 | $5.10 | +620.34% | $7.11 | +274.21% | +346.13% |
| Sep 25, 2026 | $6.95 | +881.64% | $5.73 | +201.58% | +680.06% |
| Sep 24, 2026 | $7.40 | +945.20% | $4.77 | +151.05% | +794.15% |
| Sep 23, 2026 | $7.40 | +945.20% | $3.23 | +70.00% | +875.20% |
| Sep 22, 2026 | $7.18 | +914.12% | $- | - | |
| Sep 21, 2026 | $6.62 | +835.03% | $2.63 | +38.42% | +796.61% |
| Sep 18, 2026 | $6.35 | +796.89% | $3.19 | +67.89% | +729.00% |
| Sep 17, 2026 | $6.72 | +849.15% | $3.24 | +70.53% | +778.62% |
| Sep 16, 2026 | $6.49 | +816.67% | $3.70 | +94.74% | +721.93% |
| Sep 15, 2026 | $7.03 | +892.94% | $3.95 | +107.89% | +785.05% |
| Sep 14, 2026 | $6.90 | +874.58% | $3.83 | +101.58% | +773.00% |
| Sep 11, 2026 | $0.35 | -50.99% | $4.00 | +110.53% | -161.52% |
| Sep 10, 2026 | $0.33 | -53.11% | $3.90 | +105.26% | -158.37% |
Page 1 of 5